Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells

Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells

Abstract Adjuvant chemotherapy has become the frequently adopted standard therapeutic approach for non-small cell lung cancer (NSCLC). However, the development of multidrug resistance (MDR) is a major obstacle contributing to the failure of chemotherapy. This study aimed to identify genes associated...

Full description

Bibliographic Details
Main Authors: Huaping Huang, Tangying Li, Mingjing Chen, Feng Liu, Haifeng Wu, Jie Wang, Jialiang Chen, Xi Li
Format: Article
Language:English
Published: BMC 2018-11-01
Series:Cellular & Molecular Biology Letters
Subjects:
Non-small cell lung cancer
Multidrug resistance
Microarray
Differentially expressed genes
A549/MDR
NOLC1
Online Access:http://link.springer.com/article/10.1186/s11658-018-0119-8

Internet

http://link.springer.com/article/10.1186/s11658-018-0119-8

Similar Items